HKD 2.56
(-0.78%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 483.37 Million CNY | 36.0% |
2022 | 359.33 Million CNY | -25.46% |
2021 | 482.08 Million CNY | -19.53% |
2020 | 599.09 Million CNY | 9.64% |
2019 | 546.42 Million CNY | 1.95% |
2018 | 535.97 Million CNY | -2.39% |
2017 | 549.11 Million CNY | 5.22% |
2016 | 521.84 Million CNY | 0.91% |
2015 | 517.14 Million CNY | 7.74% |
2014 | 479.98 Million CNY | -3.32% |
2013 | 496.49 Million CNY | 7.5% |
2012 | 461.44 Million CNY | 25.12% |
2011 | 369.1 Million CNY | 30.55% |
2010 | 280.21 Million CNY | 24.82% |
2009 | 226.5 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 209.68 Million CNY | 0.0% |
2023 Q2 | 183.73 Million CNY | 0.0% |
2023 FY | - CNY | 36.0% |
2023 Q4 | 263.2 Million CNY | 0.0% |
2022 Q2 | 154.03 Million CNY | 0.0% |
2022 FY | - CNY | -25.46% |
2022 Q4 | 205.29 Million CNY | 0.0% |
2021 Q4 | 222.07 Million CNY | 0.0% |
2021 Q2 | 260.01 Million CNY | 0.0% |
2021 FY | - CNY | -19.53% |
2020 Q2 | 289.12 Million CNY | 0.0% |
2020 FY | - CNY | 9.64% |
2020 Q4 | 309.97 Million CNY | 0.0% |
2019 Q4 | 263.81 Million CNY | 0.0% |
2019 FY | - CNY | 1.95% |
2019 Q2 | 282.61 Million CNY | 0.0% |
2018 Q2 | 281.62 Million CNY | 0.0% |
2018 FY | - CNY | -2.39% |
2018 Q4 | 254.34 Million CNY | 0.0% |
2017 FY | - CNY | 5.22% |
2017 Q2 | 265.06 Million CNY | 0.0% |
2017 Q4 | 284.04 Million CNY | 0.0% |
2016 FY | - CNY | 0.91% |
2016 Q4 | 262.73 Million CNY | 0.0% |
2016 Q2 | 259.11 Million CNY | 0.0% |
2015 FY | - CNY | 7.74% |
2015 Q4 | 268.94 Million CNY | 0.0% |
2015 Q2 | 248.19 Million CNY | 0.0% |
2014 Q4 | 220.36 Million CNY | 0.0% |
2014 FY | - CNY | -3.32% |
2014 Q2 | 259.62 Million CNY | 0.0% |
2013 FY | - CNY | 7.5% |
2013 Q2 | 234.98 Million CNY | 0.0% |
2013 Q4 | 261.51 Million CNY | 0.0% |
2012 Q1 | 115.36 Million CNY | 0.0% |
2012 Q2 | 115.36 Million CNY | 0.0% |
2012 FY | - CNY | 25.12% |
2012 Q3 | 115.36 Million CNY | 0.0% |
2012 Q4 | 127.81 Million CNY | 10.79% |
2011 Q4 | 115.36 Million CNY | 25.02% |
2011 Q2 | 92.27 Million CNY | 0.0% |
2011 FY | - CNY | 30.55% |
2011 Q3 | 92.27 Million CNY | 0.0% |
2011 Q1 | 92.27 Million CNY | 0.0% |
2010 Q1 | 70.68 Million CNY | 0.0% |
2010 Q3 | 70.68 Million CNY | 0.0% |
2010 FY | - CNY | 24.82% |
2010 Q4 | 92.27 Million CNY | 30.55% |
2010 Q2 | 70.68 Million CNY | 0.0% |
2009 Q2 | 56.62 Million CNY | 0.0% |
2009 Q4 | 70.68 Million CNY | 24.82% |
2009 Q3 | 56.62 Million CNY | 0.0% |
2009 Q1 | 56.62 Million CNY | 0.0% |
2009 FY | - CNY | 0.0% |
2008 Q4 | 56.62 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Starlite Holdings Limited | 71.42 Million HKD | -576.721% |
Litu Holdings Limited | 1.21 Million HKD | -39782.426% |
Touyun Biotech Group Limited | -228.56 Million HKD | 311.48% |
Champion Alliance International Holdings Limited | 35.89 Million HKD | -1246.523% |
Huaxi Holdings Company Limited | -31.47 Million HKD | 1635.548% |